跳至主要内容
临床试验/NCT07181824
NCT07181824招募中不适用

VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024

Centre Hospitalier Sud Francilien1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年8月25日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
SRLF VAP criteria

研究概览

简要总结

The goal of this observational study is to to analyze respiratory samples performed in mechanically ventilated ICU patients and to assess whether the SRLF criteria for defining VAP were respected among patients admited to the Intensive care medicine at a regional hospital en France

详细描述

Ventilator-associated pneumonia (VAP) is a lung infection that occurs after more than 48 hours of mechanical ventilation. It is of particular interest because it affects between 5-40% of ICU patients depending on the study and diagnostic criteria, with a relatively low attributable mortality (around 10%), but with increased morbidity, notably in terms of the duration of mechanical ventilation and ICU length of stay. In addition, it is the leading cause of nosocomial infection in the ICU, accounting for up to 25% of antibiotic use for hospital-acquired infections.

The diagnosis of VAP is based on clinico-radiological criteria: the appearance or worsening of a radiological pulmonary infiltrate, an inflammatory syndrome, the appearance of secretions, increased oxygen dependency and/or worsening of shock, confirmed by a positive respiratory sample.

The diagnostic challenge lies in the fact that the signs and symptoms are not pathognomonic of VAP and may be common to other conditions. On the other hand, patients may be colonized by pathogens without actually having VAP.

For this reason, scientific societies propose criteria to better target patients for whom a respiratory sample should be taken and antibiotic therapy initiated.

In 2017, the French Society of Intensive Care Medicine (SRLF) and the French Society of Anaesthesia and Intensive Care (SFAR) published recommendations on ICU-associated pneumonia, with some minor variations compared with the 2005 ATS/IDSA criteria.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥ 18 years
  • Hospitalization in Intensive care unit for the period between 01/01/2022 and 31/12/2024
  • Intubation and mechanical ventilation for > 48h
  • Positive respiratory sample

排除标准

  • Decision of therapeutic limitation
  • Organ donors
  • Patient refuse to participate

结局指标

主要结局

SRLF VAP criteria

时间窗: at day 0

Describe whether the respiratory samples obtained from ICU patients after \>48 hours of mechanical ventilation for suspected VAP met, or did not meet, the 2017 SRLF diagnostic criteria

次要结局

  • microbial ecology in the ICU of CHSF(at day 0)
  • antibiotic consumption generated by VAP(at day 0)
  • morbidity and mortality associated with VAP(at day 0)
  • duration of antibiotic therapy for a VAP episode(at day 0)
  • characteristics of the initial antibiotic therapy(at day 0)
  • Evaluate the adequacy of the initial antibiotic therapy(at day 0)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验